Funding
Sleep.ai Raises $5.3M to Expand AI Health Models and Integrations
Add Unite.AI to your preferred sources on Google
Sleep.ai announced $5.3 million in new funding on November 11, 2026, to support new partner integrations, expansion in Germany and other markets, and development of its AI-based predictive health models. Treasure Coast Ventures led the investment, with participation from the Harvard Business School Alumni Angels of Greater NY and other investors.
Sleep.ai reports that it has collected and analyzed more than 1.1 billion hours of real-world sleep data, measured longitudinally, night after night, in home settings and comprising over 200 billion data points. The company also counts 104 scientific publications behind the platform, supporting its effort to sell sleep intelligence as software rather than tie it to a single device.
The new financing follows a separate $5.5 million round announced on August 26, 2025, also led by Treasure Coast Ventures and coinciding with the company’s rebrand from SleepScore Labs to Sleep.ai. That earlier announcement put its proprietary sleep-data base at more than 800 million hours.
Making Sleep Data Consistent Across Devices
The company is using that scale to address inconsistent measurements across consumer hardware. Sleep.ai says its analysis of real-world data found typical gaps of 57 to 89 minutes when different wearable brands measured identical sleep, depending on the brand. Its platform normalizes readings across device types and works with data from approximately 800 wearables, with the aim of giving enterprise customers consistent sleep scoring regardless of the hardware their users choose.
Sleep.ai says its smartphone-based measurements include sonar that records no audio and that the platform can recognize patterns indicative of sleep-disorder risk, including sleep apnea. Partners embed the technology through APIs and SDKs, the software interfaces and toolkits that let them deliver guidance whether or not users own a wearable.
Robert Padulo, managing partner at Treasure Coast Ventures, said independence from any single device is central to the platform’s scalability because its reach is not limited by one company’s hardware sales. That argument connects the technical design to the funding’s commercial purpose: partners can add sleep features without requiring customers to standardize on one wearable.
Germany’s Reimbursed Prevention Program
Sleep.ai describes Dein Schlaf (“Your Sleep”) as a nationally reimbursed prevention program certified by Germany’s Central Prevention Testing Board. It is available without a prescription to anyone covered by German statutory health insurance, approximately 74 million people. Participating insurers include BARMER, AOK Niedersachsen, IKK Brandenburg und Berlin, and BERGISCHE Krankenkasse, and enrollment has reached 25,000 participants in 2026.
A March 13, 2026 program announcement described Dein Schlaf as a 12-week course combining contactless sleep tracking, personalized digital coaching informed by nightly data and individual goals, and adaptive behavioral guidance. It uses infrastructure compliant with the EU’s General Data Protection Regulation (GDPR), and participants receive a digital completion certificate used for reimbursement under Germany’s prevention guidelines.
Among users who tracked their sleep for 36 nights, Sleep.ai reports that two in three improved on at least two objective sleep measures compared with their own first week. Those users slept about 30 minutes longer per night and improved their sleep-quality metrics. Within that group, more than half showed progress by night 14, and nine in ten did so by night 28.
Dr. Frederike Escher-Brecht, head of digital product development at BARMER, said the app’s reliance on individually measured sleep data distinguishes it from general prevention advice because each recommendation is based on measured sleep. The program shows how those measurements can be delivered as an institutional health benefit through an insurer.
The round ties Sleep.ai’s next phase to two connected business questions: whether partners will adopt a common sleep-intelligence layer across fragmented devices, and whether reimbursed prevention can support expansion beyond Germany. The company now has a large longitudinal dataset and a reimbursed German deployment channel; converting those assets into broader partner adoption is the commercial test ahead.
